Haemodynamics and vasopressor support during prolonged targeted temperature management for 48 hours after out-of-hospital cardiac arrest: a post hoc substudy of a randomised clinical trial.

Haemodynamic parameters cardiac arrest haemodynamics mortality post-cardiac arrest syndrome targeted temperature management vasopressor

Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
17 Jun 2020
Historique:
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 20 6 2020
Statut: aheadofprint

Résumé

Comatose patients admitted after out-of-hospital cardiac arrest frequently experience haemodynamic instability and anoxic brain injury. Targeted temperature management is used for neuroprotection; however, targeted temperature management also affects patients' haemodynamic status. This study assessed the haemodynamic status of out-of-hospital cardiac arrest survivors during prolonged (48 hours) targeted temperature management at 33°C. Analysis of haemodynamic and vasopressor data from 311 patients included in a randomised, clinical trial conducted in 10 European hospitals (the TTH48 trial). Patients were randomly allocated to targeted temperature management at 33°C for 24 (TTM24) or 48 (TTM48) hours. Vasopressor and haemodynamic data were reported hourly for 72 hours after admission. Vasopressor load was calculated as norepinephrine (µg/kg/min) plus dopamine(µg/kg/min/100) plus epinephrine (µg/kg/min). After 24 hours, mean arterial pressure (mean±SD) was 74±9 versus 75±9 mmHg ( In this study, prolonged targeted temperature management at 33°C for 48 hours was associated with higher vasopressor requirement but no sign of any detrimental haemodynamic effects.

Sections du résumé

BACKGROUND BACKGROUND
Comatose patients admitted after out-of-hospital cardiac arrest frequently experience haemodynamic instability and anoxic brain injury. Targeted temperature management is used for neuroprotection; however, targeted temperature management also affects patients' haemodynamic status. This study assessed the haemodynamic status of out-of-hospital cardiac arrest survivors during prolonged (48 hours) targeted temperature management at 33°C.
METHODS METHODS
Analysis of haemodynamic and vasopressor data from 311 patients included in a randomised, clinical trial conducted in 10 European hospitals (the TTH48 trial). Patients were randomly allocated to targeted temperature management at 33°C for 24 (TTM24) or 48 (TTM48) hours. Vasopressor and haemodynamic data were reported hourly for 72 hours after admission. Vasopressor load was calculated as norepinephrine (µg/kg/min) plus dopamine(µg/kg/min/100) plus epinephrine (µg/kg/min).
RESULTS RESULTS
After 24 hours, mean arterial pressure (mean±SD) was 74±9 versus 75±9 mmHg (
CONCLUSIONS CONCLUSIONS
In this study, prolonged targeted temperature management at 33°C for 48 hours was associated with higher vasopressor requirement but no sign of any detrimental haemodynamic effects.

Identifiants

pubmed: 32551835
doi: 10.1177/2048872620934305
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2048872620934305

Auteurs

Johannes Grand (J)

Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Denmark.

Christian Hassager (C)

Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Denmark.

Markus B Skrifvars (MB)

Department of Anesthesia and Intensive Care, Helsinki University Hospital and University of Helsinki, Finland.

Marjaana Tiainen (M)

Department of Anesthesia and Intensive Care, Helsinki University Hospital and University of Helsinki, Finland.

Anders M Grejs (AM)

Department of Intensive Care Medicine, Aarhus University Hospital, Denmark.

Anni Nørgaard Jeppesen (AN)

Department of Intensive Care Medicine, Aarhus University Hospital, Denmark.

Christophe Henri Valdemar Duez (CHV)

Research Center for Emergency Medicine, Aarhus University Hospital and Aarhus University, Denmark.

Bodil S Rasmussen (BS)

Anaesthesiology and Intensive Care, Aalborg University Hospital, Denmark.

Timo Laitio (T)

Division of Perioperative Services, Intensive Care Medicine and Pain Management, Turku University Hospital, Finland.

Jens Nee (J)

Department of Intensive Care Medicine, Charité - Universitaetsmedizin Berlin, Germany.

FabioSilvio Taccone (F)

Department of Intensive Care, Erasme Hospital (ULB), Belgium.

Eldar Søreide (E)

Critical Care and Anesthesiology Research Group, Stavanger University Hospital, Norway.
Department of Clinical Medicine, University of Bergen, Norway.

Hans Kirkegaard (H)

Research Center for Emergency Medicine, Aarhus University Hospital and Aarhus University, Denmark.

Classifications MeSH